Dumato, Mecah Ella A.
HRN: 21-64-01 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/25/2022
08/01/2022
IV
225mg
Q6h
Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes